C19-IG 20%
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C19-IG 20%, covering 2022-12-05 to 2022-12-05. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of C19-IG 20% in SARS-CoV-2 Infected Asymptomatic Ambulatory Outpatients [Phase 3]